Table 1.

Clinical and laboratory parameters constituting the three evaluated scoring systems (FGSI, UFGSI, and SFGSI).

FGSI			High		Normal		Low
	+4	+3	+2	+1	0	+1	+2	+3	+4
Temp. °C	>41	39–40.9	-	38.5–38.9	36–38.4	34–35.9	32–33.9	30–31.9	<39.9
Heart rate	>180	140–179	110–139	-	70–109	-	55–69	40–54	<39
Respiratory rate	>50	35–49	-	25–34	12–24	10–11	6–9	-	<5
Serum sodium mmol/L	>180	160–179	155–159	150–154	130–149	-	120–129	111–119	<110
Serum potassium mmol/L	>7	6–6.9	-	5.5–5.9	3.5–5.4	3–3.4	2.5–2.9	-	<2.5
Serum creatinine mg/100 mL	>3.5	2–3.4	1.5–1.9	-	0.6–1.4	-	<0.6	-	-
Hematocrit (HT)	>60	-	50–59.9	46–49.9	30–45.9	-	20–29.9	-	<20
Leukocytes total/mm3 × 1000	>40	-	20–39.9	15–19.9	3–14.9	-	1–2.9	-	<1
Serum bicarbonate mmol/L	>52	41–51.9	-	32–40.9	22–31.9	-	18–21.9	15–17.9	<15
UFGSI			High		Normal		Low
	+4	+3	+2	+1	0	+1	+2	+3	+4
Temp. °C	>41	39–40.9	-	38.5–38.9	36–38.4	34–35.9	32–33.9	30–31.9	<39.9
Heart rate	>180	140–179	110–139	-	70–109	-	55–69	40–54	<39
Respiratory rate	>50	35–49	-	25–34	12–24	10–11	6–9	-	<5
Serum sodium mmol/L	>180	160–179	155–159	150–154	130–149	-	120–129	111–119	<110
Serum potassium mmol/L	>7	6–6.9	-	5.5–5.9	3.5–5.4	3–3.4	2.5–2.9	-	<2.5
Serum creatinine mg/100 mL	>3.5	2–3.4	1.5–1.9	-	0.6–1.4	-	<0.6	-	-
Hematocrit (HT)	>60	-	50–59.9	46–49.9	30–45.9	-	20–29.9	-	<20
Leukocytes total/mm3 × 1000	>40	-	20–39.9	15–19.9	3–14.9	-	1–2.9	-	<1
Serum bicarbonate mmol/L	>52	41–51.9	-	32–40.9	22–31.9	-	18–21.9	15–17.9	<15
Dissemination score	-Fournier’s gangrene confined to the urogenital and/or anorectal region, add “1” -Fournier’s gangrene confined to the pelvic region, add “2” -Fournier’s gangrene extending beyond the pelvic region, add “6”
Age score	-Age ≥ 60 years, add “1” -Age < 60 years, add “0”
SFGSI	High				Normal	Low
Serum potassium mmol/L	>7	6–6.9	-	5.5–5.9	3.5–5.4	3–3.4	2.5–2.9	-	<2.5
Serum creatinine mg/100 mL	>3.5	2–3.4	1.5–1.9	-	0.6–1.4	-	<0.6	-	-
Hematocrit (HT)	>60	-	50–59.9	46–49.9	30–45.9	-	20–29.9	-	<20